{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T07:04:20Z","timestamp":1784271860255,"version":"3.55.0"},"reference-count":53,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"Cablon BV Netherlands"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/13696998.2026.2692303","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:22:30Z","timestamp":1784269350000},"page":"1984-1997","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Casemix-based budget impact analysis of ferric derisomaltose versus ferric carboxymaltose in patients with inflammatory bowel disease and iron deficiency anaemia in the Netherlands"],"prefix":"10.1080","volume":"29","author":[{"given":"U. H.","family":"Oron","sequence":"first","affiliation":[{"name":"C3 Consultancy Cooperation","place":["Utrecht, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Koek","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Maastricht University Medical Center","place":["Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7090-5935","authenticated-orcid":false,"given":"R.","family":"Fijn","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Noordwest Hospital Group","place":["Alkmaar, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"e_1_3_3_2_1","unstructured":"Dutch Patient Information website. Accessed 12 December. 2025. https:\/\/www.crohn-colitis.nl."},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjaf017"},{"key":"e_1_3_3_4_1","unstructured":"McDowell C Farooq U Haseeb M. Inflammatory bowel disease. StatPearls. Treasure Island (FL): StatPearls Publishing; 2023."},{"key":"e_1_3_3_5_1","unstructured":"DBC Release data RZ26b published by Dutch Healthcare authority NZa; 2025; [cited 2025 Dec]. Available from: https:\/\/puc.overheid.nl\/nza\/doc\/PUC_789360_22\/1\/."},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1159\/000496728"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjad108"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2016.069"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2024.2313932"},{"key":"e_1_3_3_11_1","first-page":"d3674","article-title":"Iron suppletion in iron deficiency anemia","volume":"163","author":"Van Heek J","year":"2019","unstructured":"Van Heek J, Swinkels DW, Rennings AJM, et al. Iron suppletion in iron deficiency anemia. Ned Tijdschr Geneeskd. 2019;163:d3674.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"e_1_3_3_12_1","unstructured":"Dutch register of approved medicinal products. 2025; [cited 2025 May]. Available from: https:\/\/www.cbg-meb.nl."},{"key":"e_1_3_3_13_1","unstructured":"Dutch Pharmacotherapeutic Compass section iron deficiency anaemia. 2025; [cited 2025 May]. Available from: https:\/\/www.farmacotherapeutischkompas.nl\/bladeren\/indicatieteksten\/anemie?anchor=anemie_ijzergebreksanemie."},{"key":"e_1_3_3_14_1","unstructured":"Summary of Product Characteristics ferric carboxymaltose. RVG. 33865. Last revision 3 January; 2024."},{"key":"e_1_3_3_15_1","unstructured":"Summary of Product Characteristics ferric derisomaltose. RVG. 33865. Last revision 13 July; 2022."},{"key":"e_1_3_3_16_1","first-page":"13","article-title":"Iron therapies in iron deficiency anaemia","volume":"43","author":"Linden van der MW.","year":"2009","unstructured":"Linden van der MW. Iron therapies in iron deficiency anaemia. Dutch Medicines Bulletin. Gebu. 2009;43:13\u201318.","journal-title":"Dutch Medicines Bulletin. Gebu"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0000000000000329"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01643-5"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S243462"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.22450"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25060"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.124486"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14643"},{"key":"e_1_3_3_24_1","unstructured":"Pharmacosmos A\/S. A. randomized double-blinded comparative trial comparing the incidence of hypophosphatemia in relation to repeated treatment courses of iron isomaltoside and ferric carboxymaltose in subjects with iron deficiency anaemia due to inflammatory bowel disease. 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03466983."},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-327897"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.116202"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfx310"},{"key":"e_1_3_3_28_1","first-page":"d6078","article-title":"Ostoeomalacia after intravenous iron suppletion","volume":"165","author":"Koks N","year":"2021","unstructured":"Koks N, Donga E, Appelman-Dijkstra N. Ostoeomalacia after intravenous iron suppletion. Ned Tijdschr Geneeskd. 2021;165:d6078. [ InsertedFromOnline]","journal-title":"Ned Tijdschr Geneeskd"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/jbmrpl\/ziae064"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2024.10.596"},{"key":"e_1_3_3_31_1","unstructured":"Dutch Health Insurance Law. Accessible through; [cited 2025 Aug 12]. Available from: https:\/\/wetten.overheid.nl\/BWBR0018450\/2017-01-0."},{"key":"e_1_3_3_32_1","unstructured":"Dutch Health Ministry (Volksgezondheid. Welzijn en Sport): the Dutch Healthcare system. Januari. 2016. https:\/\/open.overheid.nl\/documenten\/ronl-5f6ea9d9-c8b5-4f2a-903b-1732d9579578\/pdf."},{"key":"e_1_3_3_33_1","unstructured":"Dutch Healthcare Authority (NZa). Sector information Hospital Care. Accessible through https:\/\/www.nza.nl\/zorgsectoren\/medisch-specialistische-zorg."},{"key":"e_1_3_3_34_1","unstructured":"NZa DBC Healthcare Products Viewer. Accessible through. 2024; [cited 2024 May\u2013July]. Available from: https:\/\/zorgproducten.nza.nl."},{"key":"e_1_3_3_35_1","unstructured":"Type coding list internal medicine specialty code 0313. 2026. Rz26b version 20230928."},{"key":"e_1_3_3_36_1","unstructured":"Type coding list pediatrics specialty code 0316. 2026. Rz26b version 20230420."},{"key":"e_1_3_3_37_1","unstructured":"Type coding list gastroenterology. 2026. specialty code 0318 Rz26b version 20230928."},{"key":"e_1_3_3_38_1","unstructured":"Type coding list geriatric rehabilitation specialty code 8418. 2026. Rz26b version 20130926."},{"key":"e_1_3_3_39_1","unstructured":"Type coding list surgery specialty code 0303. 2026. Rz26b version 20230928."},{"key":"e_1_3_3_40_1","unstructured":"Type coding list orthopedics. 2026. specialty code 0305 Rz24b version 20230928."},{"key":"e_1_3_3_41_1","unstructured":"Healthcare Activity Table. 2026. Rz26b 20240101 version 20251001."},{"key":"e_1_3_3_42_1","unstructured":"Open DBC information database of the Dutch Healthcare Authority. 2025; [cited 2025 Sep 12]. Available from: https:\/\/www.opendisdata.nl."},{"key":"e_1_3_3_43_1","unstructured":"Coding addendum (\u2018Registratieaddendum\u2019) Rz26b. 2026. v20251001."},{"key":"e_1_3_3_44_1","unstructured":"Fijn R. 2025. Real World Evaluation of the IV Ireon Service at the Alrijne Healthcare Group NL poster. et al."},{"key":"e_1_3_3_45_1","doi-asserted-by":"crossref","unstructured":"Kearns K et al. 2020. Realworld evaluation of an intravenous iron service for the treatment of iron deficiency in patients with gastroenterological disorders UK.","DOI":"10.1136\/flgastro-2020-101406"},{"key":"e_1_3_3_46_1","doi-asserted-by":"crossref","unstructured":"Kwong WJ et al. 2023. Patient-reported outcomes after Ferric Carboxymaltose treatment for iron deficiency anemia: a prospective observational study USA.","DOI":"10.2147\/IJGM.S413105"},{"key":"e_1_3_3_47_1","unstructured":"Data FER-IBD-07-COR-study as published in the SMPC of FCM. 2024."},{"key":"e_1_3_3_48_1","unstructured":"Dutch medicines pricing database based on Z-Index\/G-Standard data. 2025; [cited 2025 Dec 12]. Available from: https:\/\/www.medicijnkosten.nl."},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15386"},{"key":"e_1_3_3_50_1","first-page":"1","article-title":"Osteomalacia as a complication of intravenous iron infusion: a systematic review of case reports","volume":"2022","author":"Vilaca Y","year":"2022","unstructured":"Vilaca Y, Velmurugan N, Smith C, et al. Osteomalacia as a complication of intravenous iron infusion: a systematic review of case reports. J Bone Mineral Research Month. 2022;2022:1\u201312.","journal-title":"J Bone Mineral Research Month"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025031806"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11226843"},{"key":"e_1_3_3_53_1","unstructured":"Central Bureau of Statistics (CBS). NL mortality figure; 2022."},{"key":"e_1_3_3_54_1","first-page":"9","volume-title":"A cost-utility analysis of ferric derisomaltose versus ferric carboxymaltose in patients with iron deficiency anaemia and inflammatory bowel disease in the United Kingdom","author":"Panzer M","year":"2025","unstructured":"Panzer M, Cadman-Davies L, Kennedy NA, et al. A cost-utility analysis of ferric derisomaltose versus ferric carboxymaltose in patients with iron deficiency anaemia and inflammatory bowel disease in the United Kingdom. United Kingdom: Accounting for Difference in Fracture Risk. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Europe Glasgow; 2025. November 9\u201312."}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2026.2692303","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/13696998.2026.2692303","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2026.2692303","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:22:34Z","timestamp":1784269354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2026.2692303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/13696998.2026.2692303"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2026.2692303","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-04-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}